{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T02:56:38Z","timestamp":1775789798660,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ijrobp.2020.06.008","type":"journal-article","created":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T19:18:34Z","timestamp":1592075914000},"page":"575-586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Is There a Role for Hypofractionated Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer? A Propensity Score Matched Analysis"],"prefix":"10.1016","volume":"108","author":[{"given":"Sondos","family":"Zayed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George B.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Warner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander V.","family":"Louie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2020.06.008_bib1","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199212033272302","article-title":"A meta-analysis of thoracic radiotherapy for small-cell lung cancer","volume":"327","author":"Pignon","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib2","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1200\/JCO.1992.10.11.1819","article-title":"Role of thoracic radiotherapy in limited-stage small-cell lung cancer: Quantitative review based on the literature versus meta-analysis based on individual data","volume":"10","author":"Pignon","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1200\/JCO.1993.11.2.336","article-title":"Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group","volume":"11","author":"Murray","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199901283400403","article-title":"Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide","volume":"340","author":"Turrisi","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib5","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1470-2045(17)30318-2","article-title":"Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): An open-label, phase 3, randomised, superiority trial","volume":"18","author":"Faivre-Finn","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ijrobp.2003.10.021","article-title":"70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: Analysis of Cancer and Leukemia Group B study 39808","volume":"59","author":"Bogart","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3816\/CLC.2005.n.015","article-title":"Limited-stage small-cell lung cancer (stages I-III): Observations from the National Cancer Data Base","volume":"6","author":"Gaspar","year":"2005","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.clon.2017.09.002","article-title":"The CONVERT Trial: Interpretation, journey and lessons learnt","volume":"29","author":"Faivre-Finn","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib9","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ijrobp.2004.01.055","article-title":"Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer","volume":"59","author":"Schild","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib10","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1200\/JCO.2006.09.9606","article-title":"Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53)","volume":"25","author":"Schild","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijrobp.2014.09.042","article-title":"Phase 2 study of accelerated hypofractionated thoracic radiation therapy and concurrent chemotherapy in patients with limited-stage small-cell lung cancer","volume":"91","author":"Xia","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.radonc.2010.05.013","article-title":"Phase I dose escalation trial of hypofractionated limited-field external beam thoracic radiotherapy for limited-stage small cell carcinoma of the lung","volume":"96","author":"Yee","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib13","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ijrobp.2005.12.013","article-title":"Phase I study of hypofractionated dose-escalated thoracic radiotherapy for limited-stage small-cell lung cancer","volume":"65","author":"Yee","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib14","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/JTO.0b013e318293d8a4","article-title":"A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904","volume":"8","author":"Salama","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3747\/co.23.3023","article-title":"Management of small-cell lung cancer with radiotherapy-a pan-Canadian survey of radiation oncologists","volume":"23","author":"Shahi","year":"2016","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/0284186X.2015.1092584","article-title":"Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer","volume":"55","author":"Gronberg","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib18","unstructured":"Baldini EH, Kalemkerian GP. Limited-Stage Small Cell Lung Cancer: Initial Management. Waltham, MA: UpToDate."},{"key":"10.1016\/j.ijrobp.2020.06.008_bib19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jclinepi.2005.07.004","article-title":"A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods","volume":"59","author":"St\u00fcrmer","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13014-018-1017-y","article-title":"Stereotactic body radiotherapy for central lung tumors, yes we can!","volume":"13","author":"Korzets ceder","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib21","first-page":"32","article-title":"International statistical classification of diseases and related health problems. Tenth revision","volume":"41","author":"Bramer","year":"1988","journal-title":"World Health Stat Q"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/bimj.200810488","article-title":"Some methods of propensity-score matching had superior performance to others: Results of an empirical investigation and Monte Carlo simulations","volume":"51","author":"Austin","year":"2009","journal-title":"Biom J"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib23","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/pds.1674","article-title":"Assessing balance in measured baseline covariates when using many-to-one matching on the propensity-score","volume":"17","author":"Austin","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib24","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/sim.3150","article-title":"A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003","volume":"27","author":"Austin","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib25","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jtcvs.2007.07.021","article-title":"Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: A systematic review and suggestions for improvement","volume":"134","author":"Austin","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0895-4356(00)00321-8","article-title":"Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: A matched analysis using propensity scores","volume":"54","author":"Normand","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib27","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/sim.2328","article-title":"A comparison of propensity score methods: A case-study estimating the effectiveness of post-AMI statin use","volume":"25","author":"Austin","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib28","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/sim.2580","article-title":"A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: A Monte Carlo study","volume":"26","author":"Austin","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jacc.2016.10.060","article-title":"Comparison of propensity score methods and covariate adjustment: Evaluation in 4 cardiovascular studies","volume":"69","author":"Elze","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.prro.2020.02.009","article-title":"Radiation therapy for small cell lung cancer: An ASTRO clinical practice guideline","volume":"10","author":"Simone","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib31","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.4504","article-title":"Barriers to combined-modality therapy for limited-stage small cell lung cancer","volume":"4","author":"Pezzi","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1118\/1.2816228","article-title":"Hypofractionation in radiation therapy and its impact","volume":"35","author":"Papiez","year":"2008","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13014-017-0788-x","article-title":"Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer","volume":"12","author":"Zhang","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib34","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0360-3016(03)00635-7","article-title":"Shifting from\u00a0hypofractionated to \u201cconventionally\u201d fractionated thoracic radiotherapy: A single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation","volume":"57","author":"Videtic","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.canrad.2016.09.015","article-title":"Thoracic irradiation in 3weeks for limited-stage small cell lung cancer: Is twice a day fractionation really needed?","volume":"21","author":"Turgeon","year":"2017","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1754-9485.2012.02470.x","article-title":"A retrospective analysis of survival outcomes for two different radiotherapy fractionation schedules given in the same overall time for limited stage small cell lung cancer","volume":"57","author":"Bettington","year":"2013","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib37","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1200\/JCO.2005.02.9793","article-title":"Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer","volume":"24","author":"De Ruysscher","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib38","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJM199908123410703","article-title":"Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group","volume":"341","author":"Auperin","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib39","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/annonc\/mdf123","article-title":"Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: Analysis of 505 randomized patients","volume":"13","author":"Arriagada","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib40","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMoa071780","article-title":"Prophylactic cranial irradiation in extensive small-cell lung cancer","volume":"357","author":"Slotman","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib41","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1634\/theoncologist.2011-0169","article-title":"The effect of cigarette smoking on cancer treatment-related side effects","volume":"16","author":"Peppone","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib42","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1200\/JCO.2003.10.089","article-title":"Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival","volume":"21","author":"Videtic","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib43","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/jnci\/djm232","article-title":"18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: A systematic review","volume":"99","author":"Ung","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2020.06.008_bib44","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1200\/JCO.2015.62.4270","article-title":"Role of chemoradiotherapy in elderly patients with limited-stage small-cell lung cancer","volume":"33","author":"Corso","year":"2015","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620312499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620312499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:48:25Z","timestamp":1759744105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301620312499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0360301620312499"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.06.008","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is There a Role for Hypofractionated Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer? A Propensity Score Matched Analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}